These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27903793)

  • 1. The serotonin 5-HT
    Canal CE; Murnane KS
    J Psychopharmacol; 2017 Jan; 31(1):127-143. PubMed ID: 27903793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens.
    Kasper JM; Booth RG; Peris J
    Synapse; 2015 Feb; 69(2):78-85. PubMed ID: 25382408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT
    Gao J; Nie L; Li Y; Li M
    Neuropharmacology; 2020 Jan; 162():107848. PubMed ID: 31706992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine.
    Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
    Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine.
    Katsidoni V; Apazoglou K; Panagis G
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):337-54. PubMed ID: 20577718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT
    Leth-Petersen S; Petersen IN; Jensen AA; Bundgaard C; Bæk M; Kehler J; Kristensen JL
    ACS Chem Neurosci; 2016 Nov; 7(11):1614-1619. PubMed ID: 27564969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.
    Graves SM; Clark MJ; Traynor JR; Hu XT; Napier TC
    Neuropharmacology; 2015 Feb; 89():113-21. PubMed ID: 25229719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.
    Halberstadt AL; Sindhunata IS; Scheffers K; Flynn AD; Sharp RF; Geyer MA; Young JW
    Neuropharmacology; 2016 Aug; 107():364-375. PubMed ID: 27020041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinogens, serotonin and obsessive-compulsive disorder.
    Delgado PL; Moreno FA
    J Psychoactive Drugs; 1998; 30(4):359-66. PubMed ID: 9924841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel 1-
    Mao Q; Zhang B; Li W; Tian S; Shui W; Ye N
    ACS Chem Neurosci; 2020 Feb; 11(4):549-559. PubMed ID: 31968160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.
    Ross S
    Psychiatr Clin North Am; 2012 Jun; 35(2):357-74. PubMed ID: 22640760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.